Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole

NCT02234570 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Neurocysticercosis

Interventions

DRUG: Oxfendazole
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)